A Gene Expression Signature for RSV: Clinical Implications and Limitations
article has not abstract
Vyšlo v časopise:
A Gene Expression Signature for RSV: Clinical Implications and Limitations. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001550
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001550
Souhrn
article has not abstract
Zdroje
1. NairH, SimoesEA, RudanI, GessnerBD, Azziz-BaumgartnerE, et al. (2013) Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 381: 1380–1390.
2. OpenshawPJ, ChiuC (2013) Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol 3: 468–474.
3. NairH, NokesDJ, GessnerBD, DheraniM, MadhiSA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545–1555.
4. FalseyAR (2007) Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 28: 171–181.
5. LeeN, LuiGC, WongKT, LiTC, TseEC, et al. (2013) High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 57: 1069–1077.
6. BlankenMO, RoversMM, MolenaarJM, Winkler-SeinstraPL, MeijerA, KimpenJL, et al. (2013) Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 368: 1791–1799.
7. TurchinovichA, SamatovTR, TonevitskyAG, BurwinkelB (2013) Circulating miRNAs: cell-cell communication function? Front Genet 4: 119.
8. McNamaraPS, FlanaganBF, BaldwinLM, NewlandP, HartCA, et al. (2004) Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 363: 1031–1037.
9. JanssenR, BontL, SiezenCL, HodemaekersHM, ErmersMJ, et al. (2007) Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 196: 826–834.
10. WelliverTP, GarofaloRP, HosakoteY, HintzKH, AvendanoL, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195: 1126–1136.
11. KristjanssonS, BjarnarsonSP, WennergrenG, PalsdottirAH, ArnadottirT, et al. (2005) Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116: 805–811.
12. MunirS, HillyerP, LeNC, BuchholzUJ, RabinRL, et al. (2011) Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog 7: e1001336 doi:10.1371/journal.ppat.1001336
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- A Brief Patient-Reported Outcomes Quality of Life (PROQOL) Instrument to Improve Patient Care
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- From Ideals to Tools: Applying Human Rights to Maternal Health
- Role of DNA Methylation and Epigenetic Silencing of in Endometrial Cancer Development